Anastasiia Dudkovskaia

Anastasiia Dudkovskaia

Auto-generated profile, based on publicly available information

Anastasiia Dudkovskaia

Center for Bio- and Medical Technologies, Skolkovo Institute of Science and Technology, Moscow 121205, Russia

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 June 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
DKDmitrii Kriukov
Dmitrii Kriukov
EEEvgeniy Efimov
Evgeniy Efimov
EKEkaterina Kuzmina
Ekaterina Kuzmina
ADAnastasiia Dudkovskaia
Anastasiia Dudkovskaia
EKEkaterina Khrameeva
Ekaterina Khrameeva
DDDmitry V. Dylov
Dmitry V. Dylov
The success of clinical trials of longevity drugs relies heavily on identifying integrative health and aging biomarkers, such as biological age. Epigenetic aging clocks predict the biological age of an individual using their DNA methylation profiles, commonly retrieved from blood samples. However, there is no standardized methodology to validate and compare epigenetic clock models as yet. We propose ComputAgeBench , a unifying framework that comprises such a methodology and a dataset for comprehensive benchmarking of different clinically relevant aging clocks. Our methodology exploits the core idea that reliable aging clocks must be able to distinguish between healthy individuals and those with aging-accelerating conditions. Specifically, we collected and harmonized 66 public datasets of blood DNA methylation, covering 19 such conditions across different ages, and tested 13 published clock models. Additionally, we compiled 46 separate datasets to facilitate the training of new aging clocks. We believe our work will bring the fields of aging biology and machine learning closer together for the research on reliable biomarkers of health and aging. Code: https://github.com/ComputationalAgingLab/ComputAge Dataset: https://huggingface.co/datasets/computage/computage_bench

3 August 2025
Verified
Conference Paper
Open access
DKDmitrii Kriukov
Dmitrii Kriukov
EEEvgeniy Efimov
Evgeniy Efimov
EKEkaterina Kuzmina
Ekaterina Kuzmina
ADAnastasiia Dudkovskaia
Anastasiia Dudkovskaia
EKEkaterina Khrameeva
Ekaterina Khrameeva
DDDmitry V. Dylov
Dmitry V. Dylov

3 August 2025 in bioRxiv
Verified
Preprint
Open access
DZD.R. Zagirova
D.R. Zagirova
AKA.D. Kononkova
A.D. Kononkova
KMK.V. Morozov
K.V. Morozov
MMM.N. Molodova
M.N. Molodova
NVN.S. Vaulin
N.S. Vaulin
EKEkaterina Khrameeva
Ekaterina Khrameeva
Induced pluripotent stem cells (iPSCs) have revolutionized neuroscience, providing an approach to generate patient-specific neurons for modeling of neurological diseases. However, it remains unclear how closely iPSC-derived neurons replicate the chromatin architecture of authentic brain neurons. Here, we uniformly process datasets for 228 human and 89 mouse Hi-C and Snm3C-seq samples of different cell subtypes merged into 96 high-coverage contact maps used to examine chromatin features ranging from chromatin compartments and topologically associating domains (TADs) to chromatin loops, Polycomb-mediated contacts, and frequently interacting regions (FIREs). We find that iPSC-derived neurons largely retain chromatin state of undifferentiated cells and resemble fetal rather than mature neurons. iPSC-derived neurons exhibit unusually strong compartmentalization, an enrichment of developmental genes at TAD borders, and a marked reduction of long-range repressive Polycomb-mediated contacts that typically silence early fetal programs. Although immature, iPSC-derived neurons offer advantages for modeling interactions between disease-associated SNPs and target genes, as many psychiatric disorders have neurodevelopmental origins. Integrating iPSC-derived and postmortem neuronal datasets therefore provides complementary insights into the chromatin landscape underlying disease-associated interactions. Our study offers a valuable Hi-C resource for the community and provides a detailed comparison of chromatin architecture throughout neuronal maturation, underscoring its importance for validating neuronal models and providing a robust framework for future studies.

28 May 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
KUK.A. Ulianov
K.A. Ulianov
DZDiana R Zagirova
Diana R Zagirova
AKAnna D Kononkova
Anna D Kononkova
ADAnastasiia V Dudkovskaia
Anastasiia V Dudkovskaia
MMMaria N Molodova
Maria N Molodova
EKEkaterina Khrameeva
Ekaterina Khrameeva
Schizophrenia is a severe neuropsychiatric disorder that affects the behavioral, emotional and cognitive state of patients. Despite its substantial heritability, the molecular etiology of the disease remains poorly understood. Many schizophrenia-associated genetic variants reside in non-coding regions, and exert their effects through distal regulatory elements of the genome. In this context, the three-dimensional organization of the genome is expected to play a decisive role in establishing contacts between these regulatory elements and their target genes, thereby mediating schizophrenia-associated dysregulation of gene expression. Here, we present a novel Hi-C dataset providing an unprecedented view of three-dimensional genome organization in post-mortem schizophrenia brain samples. Our findings indicate that most changes occur at long-range genomic distances while local architecture of topologically-associated domains remains largely intact. However, neurons display localized and functionally relevant loop differences, particularly in regulatory regions associated with neurodevelopmental processes. Global characteristics of higher-order chromatin organization show accelerated aging alteration pattern in schizophrenia, and downstream analysis of transcriptomic data in schizophrenia brain samples further confirms that schizophrenia is associated with accelerated aging.